Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Biota Pharmaceuticals Inc    NABI   US6295191091

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Biota Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening infectious diseases.The Company currently has two Phase 2 clinical-stage product candidates in development: laninamivir... 
More about the company
Financials ($)
Sales 2015 21,9 M
EBIT 2015 -17,8 M
Net income 2015 -
Debt 2015 -
Yield 2015 -
Sales 2016 16,1 M
EBIT 2016 -14,9 M
Net income 2016 -
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 3,87x
Capi. / Sales 2016 5,25x
Capitalization 84,6 M
More Financials
Latest news on BIOTA PHARMACEUTICALS INC
01/05 MONDAY SECTOR LEADERS : Biotechnology, Drugs
2014 BIOTA PHARMACEUTICALS : Results of Operations and Financial Condition, Financial..
2014 BIOTA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condit..
2014 BIOTA PHARMACEUTICALS : Reports First Quarter Fiscal Year 2015 Financial Results
2014 BIOTA PHARMACEUTICALS : to Host Conference Call to Report First Quarter Financia..
2014 BIOTA PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
2014 BIOTA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
2014 BIOTA PHARMACEUTICALS : Results of Operations and Financial Condition, Financial..
More news
Sector news Bio Therapeutic Drugs
01/23 INCYTE : Earns $25 Million Milestone as Jakavi® (ruxolitinib) Recommended for Ap..
01/23 MEDIVATION : Astellas -enzalutamide phase 2 terrain trial demonstrated statistic..
01/22 QUINTILES TRANSNATIONAL : Investigator Initiated Trials is Topic of New Handbook..
Plus d'actualités du secteur Bio Therapeutic Drugs
Comments 
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF